Cellin Technologies

Executive Summary

Cellin Technologies is a European contract development and manufacturing organization (CDMO) specializing in aseptic GMP manufacturing of cell therapy medicinal products. Founded in 2015 and headquartered in Leiden, Netherlands, the company leverages over a decade of experience in adherent and non-adherent cell culture, including primary cell isolation and expansion. It operates a state-of-the-art GMP cleanroom facility and provides full cGMP-compliant services with Qualified Person release for the European market. By supporting clients from research through clinical production, Cellin addresses the growing demand for outsourced cell therapy manufacturing, particularly in Europe. The company's focus on quality and regulatory compliance positions it as a reliable partner for both academic and commercial cell therapy developers seeking to scale their processes. With the cell therapy market expanding rapidly, Cellin stands to benefit from increasing outsourcing trends as developers prioritize speed and regulatory expertise.

Upcoming Catalysts (preview)

• Q3 2026Expansion of GMP Cleanroom Capacity70% success
• Q2 2026Key Partnership with a Leading Cell Therapy Developer60% success
• Q4 2026Receipt of New Regulatory Approvals for Client Programs50% success